Beijing Airdoc Technology Co. Ltd. Class H (HK:2251)
:2251
Want to see HK:2251 full AI Analyst Report?
2251 Stock Chart & Stats
HK$12.44
-HK$0.02(-0.17%)
At close: 4:00 PM EST
HK$12.44
-HK$0.02(-0.17%)
Day’s Range― - ―
52-Week RangeHK$9.81 - HK$16.00
Previous CloseN/A
Volume16.00K
Average Volume (3M)61.23K
Market Cap
HK$1.16B
Enterprise ValueHK$457.44M
Total Cash (Recent Filing)HK$650.73M
Total Debt (Recent Filing)HK$26.93M
Price to Earnings (P/E)―
Beta0.69
Next Earnings
Aug 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding101,955,610
10 Day Avg. Volume99,440
30 Day Avg. Volume61,230
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)0.85
Price to Sales (P/S)6.06
P/FCF Ratio-49.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.37
Revenue Forecast (FY)HK$251.57M
Bulls Say, Bears Say
Bulls Say
High Gross MarginA ~66% gross margin and improving top-line demonstrate strong unit economics for the AI imaging software business. Durable high gross margins support long-term operating leverage as scale grows, enabling potential sustainable profitability if operating costs are controlled.
Conservative Capital StructureVery low leverage gives the company financial flexibility and reduces refinancing risk. This conservatism supports capacity to fund product development, regulatory work, or commercial expansion without immediate debt pressure, improving resilience over the medium term.
Recurring, Scalable Software ModelA subscription/licensing and per-use software model yields recurring revenue and high incremental margins. Combined with scalable deployment in hospitals and screening programs, this structural business model supports revenue predictability and favorable long-term unit economics.
Bears Say
Ongoing Net LossesPersistent negative net margins limit retained earnings and slow equity value creation. Even with improving revenue and gross margin, sustained losses mean profitability is not yet proven, constraining reinvestment capacity and increasing reliance on external capital.
Weak Cash GenerationNegative operating and free cash flow reduces ability to self-fund growth and increases execution risk. Volatile cash conversion history implies the company may need recurring financing to scale commercial efforts or fund R&D, which can dilute returns over time.
Negative Returns On EquityConsistently negative ROE indicates the business has not converted capital into shareholder value. This structural inefficiency may deter longer-term investors until management demonstrates sustained profitability and higher capital returns.
Beijing Airdoc Technology Co. Ltd. Class H News
2251 FAQ
What was Beijing Airdoc Technology Co. Ltd. Class H’s price range in the past 12 months?
Beijing Airdoc Technology Co. Ltd. Class H lowest stock price was HK$9.81 and its highest was HK$16.00 in the past 12 months.
What is Beijing Airdoc Technology Co. Ltd. Class H’s market cap?
Beijing Airdoc Technology Co. Ltd. Class H’s market cap is HK$1.16B.
When is Beijing Airdoc Technology Co. Ltd. Class H’s upcoming earnings report date?
Beijing Airdoc Technology Co. Ltd. Class H’s upcoming earnings report date is Aug 21, 2026 which is in 60 days.
How were Beijing Airdoc Technology Co. Ltd. Class H’s earnings last quarter?
Beijing Airdoc Technology Co. Ltd. Class H released its earnings results on Mar 31, 2026. The company reported -HK$0.249 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.249.
Is Beijing Airdoc Technology Co. Ltd. Class H overvalued?
According to Wall Street analysts Beijing Airdoc Technology Co. Ltd. Class H’s price is currently Overvalued.
Does Beijing Airdoc Technology Co. Ltd. Class H pay dividends?
Beijing Airdoc Technology Co. Ltd. Class H does not currently pay dividends.
What is Beijing Airdoc Technology Co. Ltd. Class H’s EPS estimate?
Beijing Airdoc Technology Co. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beijing Airdoc Technology Co. Ltd. Class H have?
Beijing Airdoc Technology Co. Ltd. Class H has 101,955,610 shares outstanding.
What happened to Beijing Airdoc Technology Co. Ltd. Class H’s price movement after its last earnings report?
Beijing Airdoc Technology Co. Ltd. Class H reported an EPS of -HK$0.249 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.051%.
Which hedge fund is a major shareholder of Beijing Airdoc Technology Co. Ltd. Class H?
Currently, no hedge funds are holding shares in HK:2251
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beijing Airdoc Technology Co. Ltd. Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
4.07%
12-Months-Change
Fundamentals
Return on Equity
-2.00%
Trailing 12-Months
Asset Growth
-2.84%
Trailing 12-Months
Company Description
Beijing Airdoc Technology Co. Ltd. Class H
Established in 2015 and headquartered in Beijing, China, Beijing Airdoc Technology Co., Ltd. specializes in delivering artificial intelligence-driven solutions for early detection, diagnosis, and comprehensive health risk assessment. These innovative retina-based technologies serve both medical facilities and consumer healthcare providers across Mainland China and globally. Its core product line, Airdoc-AIFUNDUS, comprises AI-powered software medical devices designed for auxiliary diagnostics. Version 1.0 assists in diagnosing diabetic retinopathy, while Version 2.0 extends this capability to hypertensive retinopathy, retinal vein occlusion, and age-related macular degeneration. The comprehensive Version 3.0 provides aid in detecting a wide array of conditions, including pathological myopia, retinal detachment, glaucoma, cataracts, ICVD/ASCVD, gestational diabetic retinopathy, gestational hypertensive retinopathy, papilledema intracranial, hypertension retinopathy, and anemia. Beyond diagnostic software, the company also develops health risk assessment tools capable of identifying risk indicators for numerous lesions and diseases. These include conditions like hyperthyroidism, Graves' ophthalmopathy, retinal vein occlusion, dementia, Parkinson's disease, atrial fibrillation, and arteriosclerosis. These solutions are deployed across diverse healthcare settings, from health checkup centers and community clinics to insurance providers, optometry centers, and pharmacies. Additionally, Beijing Airdoc supplies complementary hardware, such as specialized fundus cameras.
Technical Analysis
Ping An Healthcare and Technology Company
―
Yidu Tech, Inc.
―
Chaoju Eye Care Holdings Ltd.
―
C-MER Eye Care Holdings Limited
―
Zhaoke Ophthalmology Ltd.
―